Metroticket Calculator for Hepatocellular Carcinoma (HCC) Survival

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۹۹ • واحد: mm

حداقل ۰ — حداکثر ۱۰ • واحد: nodules

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
survival prediction
—امتیاز
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Within Up-to-Seven Criteria0–7
  • Beyond Up-to-Seven Criteria7–999
Direct Clinical Answer

The Metroticket Calculator for Hepatocellular Carcinoma (HCC) Survival calculator is designed for bedside predicting 3 and 5-year survival after liver transplantation for patients with hepatocellular carcinoma (HCC), especially those not meeting Milan Criteria in clinical practice. The resulting score directly guides clinician decision-making regarding adjusting.

Clinical Guidelines & Evidence

Predicts 3 and 5-year survival after liver transplantation for patients with hepatocellular carcinoma (HCC), especially those not meeting Milan Criteria. Uses tumor size, number, and vascular invasion status.

Clinical Indication

The Metroticket Calculator for Hepatocellular Carcinoma (HCC) Survival is indicated for bedside clinical practice to support Predicts 3 and 5-year survival after liver transplantation for patients with hepatocellular carcinoma (HCC), especially those not meeting Milan Criteria. Uses tumor size, number, and vascular invasion status.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.

Formula & Variables:

Up-to-Seven: Sum of largest tumor diameter (cm) + number of tumors ≤7. Survival prediction based on tumor characteristics matrix.

Input Parameters

NameTypeRequiredDescription
largest_nodule_sizeintegerYesSize of the largest vital tumor nodule in millimeters(mm)
number_of_nodulesintegerYesNumber of vital tumor nodules (≥1cm)(nodules)
vascular_invasionstringYesPresence or absence of vascular invasion

Score Interpretation & Guidance

RangeStageDescription
0–7Within Up-to-Seven CriteriaSum of size (cm) + number ≤7, no vascular invasion
7–999Beyond Up-to-Seven CriteriaSum of size (cm) + number >7 or vascular invasion present

Evidence-Based References (EBM)

  • Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009 Jan;10(1):35-43.
  • Mazzaferro V, Sposito C, Zhou J, et al. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. Gastroenterology. 2018 Jan;154(1):128-139.
  • Lei JY, Wang WT, Yan LN. "Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China. World J Gastroenterol. 2013 Nov 28;19(44):8093-8.

Related calculators